Upstream Bio, Inc.
UPB
$5.84
-$0.35-5.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -25.24% | 54.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.24% | 54.79% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -25.24% | 54.79% | |||
| SG&A Expenses | -12.77% | 21.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.38% | -4.67% | |||
| Operating Income | 2.86% | 5.53% | |||
| Income Before Tax | 2.19% | 4.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.19% | 4.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.19% | 4.40% | |||
| EBIT | 2.86% | 5.53% | |||
| EBITDA | 2.86% | 5.52% | |||
| EPS Basic | 2.61% | 4.83% | |||
| Normalized Basic EPS | 2.61% | 4.83% | |||
| EPS Diluted | 2.61% | 4.83% | |||
| Normalized Diluted EPS | 2.61% | 4.83% | |||
| Average Basic Shares Outstanding | 0.43% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.43% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||